# Drug combinations with amoxycillin reduce selection of clarithromycin resistance during Helicobacter pylori eradication therapy

**Type:** Papers  
**Canonical URL:** https://scholariq.org/papers/drug-combinations-with-amoxycillin-reduce-selection-of-clarithromycin-resistance/

## Facts

| Field | Value |
| --- | --- |
| Author Names | Kazushige MURAKAMI,Toshiyuki Fujioka,Tadayoshi Okimoto,Reo Sato,Masaaki Kodama,Masaru Nasu |
| Citations | 95 |
| DOI | 10.1016/s0924-8579(01)00456-3 |
| Fields | Medicine |
| Open Access | false |
| OA Status | closed |
| OpenAlex ID | https://openalex.org/W2071797781 |
| PMID | 11814770 |
| Type | article |
| Year | 2002 |

## Paper authors

- [Masaaki Kodama](https://scholariq.org/researchers/masaaki-kodama/)

## Paper journal

- [International Journal of Antimicrobial Agents](https://scholariq.org/journals/international-journal-of-antimicrobial-agents/)

## Paper primary topic

- [Helicobacter pylori-related gastroenterology studies](https://scholariq.org/topics/helicobacter-pylori-related-gastroenterology-studies/)

## Paper topics

- [Helicobacter pylori-related gastroenterology studies](https://scholariq.org/topics/helicobacter-pylori-related-gastroenterology-studies/)
- [Gastric Cancer Management and Outcomes](https://scholariq.org/topics/gastric-cancer-management-and-outcomes/)
- [Gastroesophageal reflux and treatments](https://scholariq.org/topics/gastroesophageal-reflux-and-treatments/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.